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Background: In Pakistan, 51% of women are anaemic in pregnancy yet only 44% of women use antenatal iron-folic
acid (IFA) supplements. Little information exits on the perception and barriers to the use of IFA supplements during
pregnancy in Pakistan. The aim of the study was to understand women and healthcare providers’ perceptions, and
to investigate the cultural and behavioural factors influencing the use of antenatal IFA supplements in rural and
urban settings of Pakistan.
Methods: We conducted 10 focus group discussions with mothers, 10 in-depth interviews with currently pregnant
women, 6 in-depth interviews with Lady Health Workers and 4 in-depth interviews with doctors providing antenatal
care services. The study was conducted in two districts of Pakistan - district Swabi and Islamabad for rural and urban
samples, respectively. Data was collected between August and November 2012.
Results: The majority of women were aware of the perceived benefits of antenatal IFA supplements. However, the
rural women had more limited information about the benefits of IFA supplements than the urban women. The
facilitating factors for the women’s use of supplements were: they had knowledge of benefits; they had trust in the
healthcare providers; the supplements were available; they had the financial capacity to buy them; they felt better
after taking these supplements; and they received support from family members. The barriers to the women’s use
of supplements were: they forgot to take them; the non-availability of supplements; their limited financial capacity
to buy them; the lack of antenatal care services; family members not allowing use of the supplements; not knowing
about the benefits or no education; fear or experience of side effects; considering them as contraceptives; and felt
better thus stopped.
Conclusion: The coverage of antenatal IFA supplementation can be improved by reducing the barriers related to
the use of antenatal IFA supplementation in Pakistan. Interventions focused on providing adequate awareness,
good quality counselling, reminder messages, availability of free supplements throughout pregnancy and reducing
the side effects should be developed and implemented.
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There are 1.62 billion anaemic people, which is a quarter of
the global population [1]. Approximately 42% of pregnant
women are anaemic worldwide [1], whereas the prevalence
of anaemia among Pakistani pregnant women is higher
with 51% of them anaemic at any stage during their* Correspondence: drbin01@hotmail.com
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unless otherwise stated.pregnancy [2]. Iron deficiency is the most common
cause of the anaemia during pregnancy and it is the
most widespread nutritional deficiency in the world
[3,4]. It has been observed that anaemia during preg-
nancy is associated with an increased risk of maternal
mortality [5], low birth weight [6-8] and prematurity
[6,8,9]. To prevent anaemia during pregnancy, the
World Health Organization recommends, as a part of
antenatal care (ANC) programs, a standard daily oral dose
of 30–60 mg iron and 400 μg folic acid supplements tod. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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pregnancy [10]. A recently published meta-analysis has
identified a significant reduction of 19% in the risk of
low birth weight associated with the use of antenatal
iron supplements [11]. Further, a pooled analysis of data
from four Indonesian demographic and health surveys
(1994, 1997, 2002–03 and 2007) showed a significant
39% reduction in neonatal mortality with antenatal
iron-folic acid (IFA) supplementation [12].
In Pakistan, antenatal IFA supplements (elemental iron
60 mg and folic acid 0.5 mg) are distributed free of cost
by maternal and child health services through the existing
primary healthcare system including health facilities and
the community health worker program, known as the
Lady Health Workers (LHW) program for daily consump-
tion throughout the pregnancy starting from second tri-
mester. However, the overall level of consumption of
antenatal IFA supplements at any stage during pregnancy
is currently low in Pakistan (44%), and is even lower for
rural women (38%) [13]. Moreover, 16% overall and 12%
of the rural women consumed 90 or more supplements
throughout their pregnancy [13]. In comparison with
other South Asian countries such as Bangladesh [14],
India [15], and Nepal [16,17] the coverage of antenatal
IFA supplements is the lowest in Pakistan [13]. The
current low coverage of IFA supplements needs to be in-
vestigated further to understand the issues related to these
programs in Pakistan. Further research in this field will
help to develop interventions to improve the coverage of
antenatal IFA supplementation.
Evidence from developing countries suggests that the
outcome of antenatal IFA supplementation programs is
influenced by the behaviour of the pregnant women and
the healthcare providers. The pregnant women reported
they forget or were unwilling to take the supplements,
while healthcare providers gave inadequate counselling
and distribution of iron tablets [18]. Qualitative research
can help in understanding the behaviour of the pregnant
women and their healthcare providers related to the use
of IFA supplements. Subsequently, the findings of this
qualitative research can assist stakeholders from the
government and non-government organizations (NGOs)
to develop and implement better behaviour change
communication interventions to improve the coverage
in Pakistan. The aim of the current study was to under-
stand the women and the healthcare providers’ percep-
tions and to investigate the cultural and behavioural issues
related to the use of antenatal IFA supplements in rural
and urban settings of Pakistan.
Methods
Study design, study sites and population
In this study, in-depth interview (IDI) and focus group
discussion (FGD) methods were used to capture datafrom selected rural and urban settings in two districts of
Pakistan. The rural sample was selected from the district
of Swabi while the urban part was conducted at the
Pakistan Institute of Medical Sciences (PIMS), Islamabad.
PIMS is the largest tertiary care, teaching hospital in
Islamabad, the capital city of Pakistan. The institute has
three major components – the Islamabad Hospital for adult
patients with many sub specialties; the Children’s Hospital
for paediatric patients; and the Maternal and Child Health-
care Centre for gynaecology and obstetrics patients.
The two study districts were selected based on pre-
dominant urban and rural settings, socioeconomic status
and prevalence of use of IFA supplements during preg-
nancy. In Swabi district, 69% of women had no education,
the total fertility rate was 3.1, 67% of respondents had at
least one ANC visit [19] and 45% of women consumed
antenatal IFA supplements during their most recent live
birth 5 years prior to the survey [20]. In comparison, in
Islamabad region 16% of women had no education, the
total fertility rate was 3.0, 97% of women had at least one
ANC visit and 80% of women consumed antenatal IFA
supplements during their recent live birth within 5 years
prior to the survey [21].
Four main categories of participants were identified
who are involved in the antenatal IFA supplementation
and therefore, we included participants from these four
categories in the study. These are: (a) the rural and the
urban currently non-pregnant mothers who gave birth
within five years prior to the study; (b) the rural and the
urban currently pregnant women; (c) the community
health workers [Lady Health Workers (LHWs)] who are
responsible for providing antenatal IFA supplements to
pregnant women in the rural communities; and (d) the
doctors working in a tertiary care hospital, who are pro-
viding IFA supplements to pregnant women in the urban
settings. We did not consider including traditional birth
attendants because antenatal care services are mainly
provided by healthcare providers and only 2.4% of rural
women received ANC services from traditional birth
attendants in Pakistan [21]. The details of background
characteristics of participants are given in Table 1.
Ethics
Informed consent was obtained from each of the partici-
pants for the IDIs and FGDs. Ethical and institutional ap-
provals were obtained from the Hospital Ethics Committee,
Pakistan Institute of Medical Sciences, Islamabad, from the
Lady Health Workers’ program, Swabi district, and from
the Human Research Ethics Committee, the University of
Sydney, Australia.
Sampling
Sampling was purposive and the respondents were selected
from the urban and the rural areas. Figure 1 summarizes
Table 1 Basic characteristics of respondents
Characteristics
Currently pregnant women1 (n = 10) Currently non-pregnant women2 (n = 73)
Rural (n = 6) Urban (n = 4) Rural (n = 47) Urban (n = 26)
Age
Less than 25 3 (50.0%) 2 (50.0%) 8 (17.0%) 6 (23.1%)
25 to 34 years 1 (16.7%) 1 (25.0%) 19 (40.4%) 12 (46.2%)
35 and more 2 (33.3%) 1 (25.0%) 20 (42.6%) 8 (38.7%)
Respondents educational status
Illiterate 3 (50.0%) 1 (25.0%) 29 (61.7%) 5 (19.2%)
Primary 2 (33.3%) 1 (25.0%) 12 (25.5%) 6 (23.1%)
Secondary and above 1 (16.7%) 2 (50.0%) 6 (12.8%) 15 (57.7%)
Husband's educational status
Illiterate 2 (33.3%) 1 (25.0%) 22 (46.8%) 3 (11.5%)
Primary 2 (33.3%) 0 (0.0%) 16 (34.0%) 7 (26.9%)
Secondary and above 2 (33.3%) 3 (75.0%) 9 (19.1%) 16 (61.5%)
Duration of current pregnancy
First trimester 1 (16.7%) 1 (25.0%) NA NA
Second trimester 1 (16.7%) 3 (75.0%)
Third trimester 4 (66.6%) 0 (0.0%)
Number of children
First time pregnant 1 (16.7%) 2 (50.0%) NA NA
1 to 3 3 (50.0%) 2 (50.0%) 26 (55.3%) 16 (61.5%)
4 and more 2 (33.3%) 0 (0.0%) 21 (44.7%) 10 (38.5%)
Age of the youngest child
First time pregnant 1 (16.7%) 2 (50.0%) NA NA
Less than 18 months 4 (66.6%) 0 (0.0%) 14 (29.8%) 13 (50.0%)
18 to 36 months 1 (16.7%) 2 (50.0%) 21 (44.7%) 6 (23.1%)
More than 36 months 0 (0.0%) 0 (0.0%) 12 (25.5%) 7 (26.9%)
1Currently pregnant women were involved in in-depth interviews.
2Currently non-pregnant women were involved in focus group discussion.
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istrative unit in a district is a union council, with an average
population of 10,000 people and has a government primary
health facility (basic health unit/ rural health centre). In
Swabi district, there are 56 union councils. We selected
three primarily rural union councils, with operational
government primary health facilities and served by the
LHW program. From each union council, two LHW
served areas were selected. In each LHW area, one FGD
with mothers and one IDI each with pregnant woman
and LHW were carried out. In the urban setting, both
FGDs and IDIs were carried out at the PIMS, Islamabad.
The doctor on duty to providing ANC services at the
outpatient department of the PIMS Maternal and Child
Health Centre at the time of data collection was inter-
viewed. The currently pregnant women who visited the
duty doctor at the PIMS Maternal and Child Healthcare
Centre, for ANC services on that day were also interviewed.The currently non-pregnant mothers from Islamabad, who
came with their sick children to the Children’s Hospital of
the PIMS were invited for FGDs.
Data collection process
Separate guidelines were developed for the FGD with
the currently non-pregnant women/mothers and for the
IDIs with the currently pregnant women, LHWs and the
doctors. These interview tools were translated into Urdu
(the language spoken by the study participants). A fe-
male doctor and two social scientists were hired and
trained in the study objectives, methodology and the
guidelines. We pre-tested the data collection guide-
lines in the urban and the rural communities of the
participating districts, but in locations where actual
data collection was not done. The guidelines were then
modified on the basis of the findings of the pre-testing.
The major topics contain perceptions about iron-folic
Figure 1 Sampling frame for the study.
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riers and facilitating factors for IFA supplements use in
pregnancy.
In rural areas, the village leader of the selected LHW
area was informed about the purpose of the study before
the commencement of data collection. The village leader
contacted the LHW working in the selected area and the
investigators invited her to participate in the study. Then,
the local LHW identified the currently non-pregnant
mothers and the pregnant women living in her village and
the investigators invited them to participate in the study.
Moreover, the women for IDI were further stratified by
socio-economic status, with participants from three differ-
ent classes, such as high socio-economic status, middle
socio-economic status and low socio-economic status.
After informed consent, the session/interview was com-
menced according to the guidelines. A series of questions
were asked to understand the perceptions of the partici-
pants about the use of antenatal IFA supplementation.
Furthermore, the behavioural and cultural issues in terms
of the facilitating factors and the barriers to the use of
antenatal IFA supplementation were also explored. The
average time for the FGDs was 1 hour and 20 minutes
and 45 minutes for the IDI. All the information/discus-
sions were audio recorded and the key information was
also noted by hand. At the end of each session, the investi-
gators provided, to all the participants, information about
the use of antenatal IFA supplementation, and its impact
on maternal health, and the growth and development of
the newborn. The average number of participants per
FGD was 7 women.Data analysis
Two investigators (YBN and BA) independently tran-
scribed the audio recorded interviews and discussions ver-
batim and expanded the field notes in Urdu (the language
spoken by the study participants). Audio-recordings and
notes were then translated into English. YBN and BA de-
veloped a list of topical codes for all topics related to the
research questions that was independently reviewed and
verified by another investigator (AA). Subsequently the
text pertaining to each topical code was discussed and
summarised in a document that presents the findings for
each topic using quotes and tables. NVivo version 10
(QSR International, Victoria Australia) was used to aid the
data organisation and analyses.
Results
Profile of study participants
Forty seven rural and 26 urban mothers participated in 6
and 4 FGDs respectively. The IDIs were conducted with
six rural and 4 urban currently pregnant women. The
basic characteristics of all women, who participated in
the study from the rural and urban communities, are
shown in Table 1. The IDIs were conducted with the six
LHWs working in the Swabi district and with the four
doctors working at the PIMS Maternal and Child Health
Centre, Islamabad.
Perception of IFA supplements
The majority of the participating women were aware of
antenatal IFA supplementation. The rural women
knew the supplements by names such as ‘tablets to
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limited information about the IFA supplements and
their benefits. A few of the rural women reported about
the supplements as providing strength to their weak bod-
ies during the pregnancy; curing dizziness, lethargy and
the back pain; improving maternal health and wellbeing;
needing to be taken once daily and continued throughout
the pregnancy; and to prevent complications during the
pregnancy and at the time of delivery.
“These tablets are good to provide strength to our
bodies which are weak during the pregnancy, and also
improve the feeling of dizziness; these tablets are good
for my health” (A rural mother of three children
who participated in FGD).
“It prevents the complications during the
pregnancy and at the time of delivery”
(A currently pregnant rural woman who
participated in IDI).
The urban women, on the other hand, were aware of
the various brand names of the supplements available in
the market. A substantial majority of the urban women
were able to describe the supplements and reported the
benefits of the supplements as improving the haemoglobin
level; improving the appetite; curing anaemia; needing to
be taken once daily and continued throughout pregnancy;
improving maternal health and the health and growth of
the foetus/baby; preventing delivery complications; and
taking a good diet (such as vegetables and meat) along
with the supplements.
“These [supplements] are good to take during the
pregnancy because these improve the haemoglobin
levels and improve the health of mother and
health and growth of the baby inside the mother’s
womb” (A currently pregnant urban woman who
participated in an IDI).
Nevertheless, some of the selected women were not aware
of the antenatal IFA supplements. They had no information
about the supplementation program and the benefits of the
supplements. They reported several reasons for their lack of
awareness and the common reasons included: no visits by
the LHW because they lived some distance away; no visits
by them to any health facility during pregnancy; poverty and
no education; and no information given to them by the doc-
tors even when they visited a health facility.
“We live on the other side of the village and she [LHW]
doesn’t come to our house; we are very poor and it is
difficult for us to go to a hospital” (A pregnant rural
woman who participated in an IDI).All the participating LHWs and the doctors were
aware of the IFA supplements and their health benefits.
LHWs reported that the women in their communities
knew about the supplements and called these supplements
as ‘tablets to provide the strength’, ‘red tablets’ or ‘blood
producing tablets’.
“These tablets are good for the health of pregnant
women because they face many hardships during their
pregnancy; they feel weakness and dizziness; these
tablets cure them and provide them strength; here
[village] women know about these tablets as to provide
strength, while some of them call them as tablets to
produce blood” (A LHW working for the last 7 years
who participated in an IDI).
The doctors reported that the majority of the pregnant
women who visited the health facility knew about the
supplements and that a few of them even knew the
brand names available in the market.
Source of information about antenatal IFA supplements
The great majority of the rural women reported receiv-
ing information about IFA supplementation from the
LHWs, and a few of them also reported receiving infor-
mation from doctors when they visited health facilities.
The urban women received the information about the
supplementation from a variety of sources. Most of
them received information from doctors, but some of
them also received information from their family mem-
bers, friends, neighbours, televisions or from newspa-
pers/magazines.
Sources of antenatal IFA supplements
The major sources of the antenatal IFA supplements
stated by the women were LHWs (rural women); govern-
ment health facilities; and private clinics or pharmacies.
The majority of rural women reported that when they vis-
ited healthcare providers for problems related to their
pregnancy they received or were prescribed IFA supple-
ments. The common problems for which they sought care
included back pain, feeling weak, dizzy and lethargy. A
few of them also visited the healthcare providers for rou-
tine ANC services and also received IFA supplements.
“I was not feeling well few months ago, as I had severe
back pain and feeling weak; my mother took me to a
private clinic and the doctor over there prescribed me
these tablets along with some other medicines”
(A rural woman pregnant for the first time who
participated in an IDI).
Among the urban women, some of them went to the
health facility for the routine ANC services and received
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health facility due to some problems related to their
pregnancy and received the supplements. Occasionally, a
family member also advised urban pregnant women to
use these supplements.
“I was admitted to the hospital because I had
some internal problems with bleeding during my
previous pregnancy; the senior doctor prescribed
me these tablets at the time of discharge”
(An urban mother of three children who
participated in a FGD).
Reasons to use antenatal IFA supplements - facilitating
factors
The women reported several reasons for using IFA
supplements during pregnancy including: they had
knowledge of the benefits of the supplements; they had
trust in the healthcare providers; the supplements were
available and they had the financial capacity to buy
them; they felt better after taking the supplements; and
they received support from family members to take the
supplements.
“I know these tablets are good to provide strength to
body which is weak during pregnancy, and also
improve dizziness; these tablets are good for my
health” (A rural mother of three children who
participated in a FGD).
“When I was pregnant my sister-in-law advised me to
take these tablets because these tablets have advan-
tages for myself and for the health of my child;
afterward, doctor in this hospital also told me
about them”
(An urban woman pregnant for the first time who
participated in an IDI).
LHWs reported that they provided the supplements to all
the pregnant women because they were a part of the routine
care during the pregnancy; to improve the health of the
pregnant women; and to cure anaemia or low haemoglobin
levels during the pregnancy.
“When I visit them [pregnant women] for check up
during their pregnancy, I provide them these tablets;
sometime pregnant women have some health
problems like weakness, dizziness, so I provide them
these tablets and they feel better afterwards” (A LHW
working for 4 years who participated in an IDI).
The doctors also stated various reasons to prescribe the
supplements to all the pregnant women visiting them, in-
cluding that they are a part of routine ANC services; dueto poor dietary habits of the pregnant women; due to signs
or symptoms of anaemia, or low measured haemoglobin
levels; and to improve maternal health and growth and
the development of the newborn.
Timing of the start of antenatal IFA supplements
A substantial majority of the women started the antenatal
IFA supplementation during the second trimester of their
pregnancy. LHWs reported distributing the IFA supple-
ments to all the pregnant women in their catchment area
from the 4th or 5th month of their pregnancy onwards.
While doctors also reported that they prescribed IFA
supplements during the second trimester of pregnancy
to the pregnant women who visited the hospital, either
for routine check-ups or with some specific problems.
Barriers to antenatal IFA supplementation
The common barriers to the use of IFA supplements
reported by the urban and rural women included forget-
ting to take them on a daily basis; the non-availability of
the supplements; their limited financial capacity to buy
them; no ANC services available; family members such
as mother-in-law, husband or mother did not allow them
to use the supplements; they did not know about the ben-
efits and they had no education; they were afraid of the
supplements or they had experienced side effects (like
vomiting, nausea or constipation); and they considered
them to be like contraceptives. In addition, the urban
women also reported that they felt better and stopped the
IFA supplementation after few days without consultation
with their healthcare providers.
“I stopped these after few days because I forgot to take
on each day as I have many duties to perform at home
and difficult to remember on each day” (A rural
mother of three children who participated in a
FGD).
“I used these tablets but after few days I had vomiting
and diarrhoea with these and my mother-in-law told
me to stop this medicine; she [mother-in-law] told me
not to take any medicine during pregnancy”
(An urban currently pregnant woman who
participated in an IDI).
According to healthcare providers the common barriers
to the use of IFA supplements were: the women forgot to
take them daily; family members mainly mother-in-law
and husband did not allow the women to use them; the
woman felt better and stopped without consultation; the
women did not take medicines during the pregnancy; the
supplements were not available or the woman had limited
financial capacity to buy them; the woman did not visit
healthcare providers; fear of the supplements or previous
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women did not know the advantages of these supple-
ments; and the women had no education.
“There are some women in my village who do not
follow our advice because their family [husbands or
mothers-in-law] don’t allow them; as they think it is
bad to take medicines during pregnancy because
medicines have some negative effects on baby’s
health” (A LHW working for 12 years who
participated in an IDI).
The majority of the women were of the view that they
would like to use the supplements in the future. However,
some of them wanted to receive the supplements in an
adequate quantity and free of charge throughout the
pregnancy. They also wanted to recommend the supple-
ments to other pregnant women in their family or neigh-
bourhood. A few of them, who had experienced some side
effects or were not aware of the benefits associated with
the supplements, did not want to recommend the supple-
ments to other pregnant women.Pathways of procurement of antenatal IFA supplements
by a pregnant woman
Figure 2 summarizes the women’s and the healthcare
providers’ perceptions of the process of procurement of
antenatal IFA supplements by a pregnant woman. When
a woman becomes pregnant, she is likely to discuss her
pregnancy and what she needs to do with her family
members, such as mother-in-law, husband, mother or
sisters-in-law. Often, a family member will take her to
the health facility (government/private) or LHW (in the
rural communities), for routine check-ups or for a health
problem. If the woman visits a LHW, the IFA supple-
ments when available are provided free of charge, but if
the LHW does not have a supply, the woman will be re-
ferred to a government health facility. If she visits a gov-
ernment health facility, she will either receive the IFA
supplements free of charge, or if the supplements are
not available at the government health facility, the doc-
tor will prescribe them for her. Similarly, if she visits a
private clinic, the healthcare provider prescribes her the
supplements. Once she gets the prescription, sometimes
she will purchase the supplements from a pharmacy. A
pregnant woman will not use IFA supplements during
her pregnancy if she does not receive any ANC services,
or if her family members (mother-in-law, husband,
mother) do not allow her to use them, or if she avoids
taking medicines during pregnancy, or if she is not
aware of IFA supplements and their benefits, or if
she has limited financial capacity to purchase the
supplements.Pathways of consumption of antenatal IFA supplements
by a pregnant woman
Figure 3 summarizes the pathways of perceptions of the
women and the healthcare providers about the con-
sumption of IFA supplements by a pregnant woman.
Once a pregnant woman receives the supplements,
sometimes she discusses their use with a family member
mainly with her mother-in-law, husband, and mother or
occasionally with her sisters-in-law, who may or may
not allow her to take them. She may continue taking the
supplements regularly if she perceives the benefits of the
supplements, or if she trusts her healthcare provider, or
if the supplements are available, or if she has the finan-
cial capacity to purchase them, or if her family members
support her taking them, or if she feels an improvement
in her health. She may not take IFA supplements at all
or she may stop the supplements after using them for
few days or weeks if she forgets to take them each day,
or if she is not aware of the need to continue taking
them throughout her pregnancy, or if she feels better
and stops without consulting her healthcare provider, or
if she is not aware of the advantages of the supplements,
or if she is not able to obtain a continuing supply of the
supplements (non-availability), or if she has limited fi-
nancial capacity to buy them, or if she experiences some
side effects.
Discussion
Main findings and their significance
This study found that most of the women were aware of
antenatal IFA supplementation and the benefits of the
use of these supplements during pregnancy for maternal
health and growth of the foetus/baby. However, the rural
women’s perceptions about the benefits of the use of
antenatal IFA supplements were mainly focused on ma-
ternal health. Whereas, the urban women had better
knowledge and they were more aware of the advantages
of supplementation such as curing anaemia, improving
haemoglobin levels and improving foetal growth and de-
velopment. The healthcare providers reported prescrib-
ing or providing the supplements to all the pregnant
women who visited them. The information received by
the pregnant women about the supplements from the
healthcare providers was not uniform and did not ex-
plain the various aspects of the supplements, such as the
description and management of minor side effects, pos-
sible ways to remember to take the supplements daily,
and explanations of the advantages of the supplementa-
tion. The current study also investigated several facilitat-
ing factors and barriers to the use of IFA supplements.
The recognized behavioural and cultural issues which in-
fluence the use of IFA supplements among urban and
rural Pakistani women can play a useful role in the de-
velopment of interventions to improve the coverage.
Figure 2 Pathways for the procurement of IFA supplements by a pregnant woman. 1 Family member: mother-in-law, mother, husband or
sister-in-law. 2 Lady Health Worker. 3 Iron-folic acid supplements.
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cation interventions for IFA supplementation at the na-
tional, provincial and the district level. Further, a
separate set of interventions are required to test in
urban and rural settings of Pakistan to improve the
coverage of IFA supplements.
Strengths and limitations
The current study provides valuable information about
the perceptions of women and the healthcare providers
about the antenatal IFA supplementation in the urban
and the rural communities of Pakistan. However, the re-
sults are not intended to be representative of all districts
in Pakistan. The major strength of our study is that we
conducted interviews with mothers, currently pregnant
women and the healthcare providers including the com-
munity health workers and the doctors providing ANC
services using different qualitative data collection tech-
niques. Further, the sample was selected from urban and
rural communities to understand and compare the per-
ceptions of women and healthcare providers in these
settings.
There are several limitations of this study. We did not
collect data about perceptions of family members such
as husband, mother-in-law and mother, and the healthmanagers in the department of health about the ante-
natal IFA supplementation. Women who usually come
to PIMS for ANC services may have better knowledge of
IFA supplements, which might be a study limitation.
However, we wanted to investigate the perceptions of
women, who usually come to a health facility for ANC
services and thus included the women receiving ANC
services from the PIMS as well. We did not investigate
the quality of counselling and information imparted by
the healthcare providers by direct observation at the
time of provision/ prescription of the IFA supplements.
Hence, further investigation is needed to examine these
issues.
Facilitating factors
Facilitating factors for the use of antenatal IFA supple-
ments recognised in our study were the perceived benefits
of supplementation; the trust in the healthcare providers;
the accessibility of the supplements and the financial
capacity to buy them; support for their use from family
members; and the experience of positive impact of the
supplements.
Our study findings are consistent with other studies.
Perceived and experienced benefits of the IFA supplemen-
tation was one of the important facilitating factors in our
Figure 3 Pathways for the consumption of IFA supplements by a pregnant woman. 1 Iron-folic acid supplements. 2 Family member:
mother-in-law, mother, husband or sister-in-law.
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USA [22] and Sweden [23] have reported perceived and
experienced benefits of the supplementation as important
motivating factors for the use of supplements during preg-
nancy. Similarly, studies from the developing countries
such as Senegal [24], Nigeria [25], and India [26] found
this as a key factor for the consumption of IFA supple-
ments during pregnancy. A multi-country study including
eight countries from Asia, Latin America and Africa also
reported perception or experience of benefits was an
important facilitating factor [18]. Research has shown that
pregnant women complied with supplementation when
they were provided the necessary information at the
time IFA supplements were provided [27]. It is, there-
fore, important for healthcare providers to explain all
the advantages of IFA supplementation to the pregnant
woman at the time the supplements are provided or
prescribed. Enhanced training of healthcare providers
and use of mobile technological can improve the counsel-
ling skills of healthcare providers especially in rural areas.
Our study showed that women used IFA supplemen-
tation if they had confidence and trust in the health-
care providers who prescribed or provided the IFA
supplements. It is important that healthcare providers
develop strong interactions with pregnant women
while providing them with ANC services. Interaction and
confidence in healthcare providers has been recognized asan important factor for the use of antenatal IFA supple-
ments [22-25]. Good counselling from a healthcare pro-
vider has been reported to improve the compliance with
IFA supplementation during pregnancy [27].
Accessibility or financial capacity to buy the supple-
ments was also a facilitating factor in our study. Research
has shown that easy accessibility, supplements free of
charge or even the availability of low cost supplements im-
proved the use of antenatal IFA supplements [22,24,27].
In Pakistan, free IFA supplements are being distributed to
pregnant women through the government health facilities
and the LHW program. Women who live close to the
government health facilities or in a LHW program area
can obtain IFA supplements free of charge. However, the
supplements are often neither available with LHW nor at
government health facilities. There is a need to strengthen
the current logistic system of LHW program and the
health department at district level. Whereas, sometimes it
is difficult for women who either do not live in a LHW
service area, or are far from a government health facility to
obtain these supplements free of charge. Alternate ways
such as involvement of community volunteers and trad-
itional birth attendants through non-governmental organi-
zations for provision of the supplements to the pregnant
women in non-LHW service areas should also be explored.
An important facilitating factor for IFA supplementation
in our sample was the support from the family member,
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[22,25,26]. Pakistani women during their pregnancies
usually dependent on the decisions of their family
members (particularly husband, mother-in-law or
mother) on several occasions including utilizing ANC
services, taking medicines, deciding the place of deliv-
ery, type of delivery assistance and the need for postna-
tal care. While, most of the time, the decisions of
family members depend on their financial capacity and
their level of education. There is a need to provide
health education to family members such as husband,
mother-in-law and mother through community level
advocacy campaigns.
Barriers
Similar to many other studies forgetting to take sup-
plements daily was the most common barrier to ante-
natal IFA supplementation in the women we studied
[18,22-24,28]. Women have reduced short-term memory
during pregnancy and a recently published systematic
review has found that pregnant women performed more
poorly than non-pregnant women on memory and other
cognitive tests [29]. At the same time, many pregnant
women have to perform several tasks at home throughout
the day and they often forget to take the supplements
on a daily basis. As suggested by one of the doctors in
our study, ‘pregnant woman should keep the supple-
ments in home where she spends most of the time
during the day like in kitchen’. Further, there is a need
to provide continuous messages to remind the preg-
nant women through family members, healthcare pro-
viders or through the use of mobile phones to improve
compliance with the daily consumption of antenatal
IFA supplements [30].
Non-availability or limited financial support to purchase
the supplements after receiving prescriptions from
healthcare providers was one of the barriers to the use
of antenatal IFA supplements in the women we inter-
viewed. Others have also reported similar findings in
their studies [18,24,31]. Distribution of IFA supplements
through community health workers is a good alternative
to distribution by health facilities in developing countries,
where accessibility to health facilities is limited [18,32].
However, often it is difficult for the pregnant women to
receive adequate quantity of supplements due to frequent
stock out and the provision of supplements on a quota
system (not according to actual demand) to the LHWs.
There is a need to strengthen the logistic system for
supplying IFA supplements to LHWs as well as to the
health departments at the district and the provincial levels.
Many women stated that the experience or fear of
gastrointestinal side effects as one of the barriers to the use
of IFA supplementation during pregnancy. Several studies
have considered the presence of side effects as the majorbarrier to the IFA supplementation [18,22-24,26,28,31],
leading many to advocate weekly instead of daily sup-
plementation, and others to suggest alternative iron
preparations to reduce side effects [33]. However, a
study from Bangladesh found that the side effects have
limited impact on the use of IFA supplements during
pregnancy [34]. Women, even having some minor
gastrointestinal side effects, continued using the supple-
ments if they perceived or experienced benefits of the
supplementation [18,26]. Hence, the quality of counselling
is important to overcome this problem.
As with other studies [18,24,31], we found the lack of
awareness of the benefits of IFA supplements, lack of
knowledge to continue the supplements or feeling better
and stopping the supplementation were also considered
as barriers to the use of IFA supplements. A clear message
at the time of initiation of the supplements by the health-
care provider can overcome this barrier. Similarly, alterna-
tive counselling techniques like use of mobile phones
messages [30] and counselling in places of worships such
as mosque have shown a positive impact on the use of IFA
supplements in Nigeria [25].
Program implications
Our study findings have implications for the IFA sup-
plement distribution programs in Pakistan. In low- and
middle-income countries where it is often difficult to
reach health facilities in resource poor communities,
the distribution of the IFA supplements through commu-
nity health workers is a successful approach [18,32]. In
this context, the LHW program, which was launched in
1994 by the Government of Pakistan, has been providing
ANC services including supply of IFA supplements to all
the pregnant women in its catchment area [35]. Currently,
about 60% of the total population of Pakistan is covered
by the LHW program. Based on our findings, to improve
IFA supplementation in the LHW service areas there is a
need to retrain the LHWs for better counselling, reminder
text and voice messages by using the mobile technology
[30], and to improve the logistic system of the program
on current demand and supply. At the same time, in
the non-LHW program areas, where the government
health facilities are the only source for free supplemen-
tation, alternative ways to reach the pregnant women
like recruiting volunteers and involving traditional
birth attendants in the distribution program of the
supplements should also be explored. Nepal has im-
proved the IFA supplementation coverage from 23% in
2001 [36] to 80% in 2011 [16] by running a package of
successful interventions [37]. There is a need to modify
and test the feasibility and effectiveness of these inter-
ventions through multi-sites, community based trials
with large sample size in resource poor communities of
Pakistan.
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The current study reveals that awareness of benefits,
confidence in healthcare providers, accessibility or finan-
cial capacity, receiving support from family members
and experience of the health benefits of the supplements
were the facilitating factors for the use of antenatal IFA
supplements in rural and urban settings of Pakistan.
Forgetfulness, the non-availability or lack of financial
capacity to buy, experience of gastrointestinal side effects,
lack of knowledge about the benefits, and the lack of
knowledge to continue, or stopping on recovery were the
barriers to the use of antenatal IFA supplements in rural
and urban areas of Pakistan. The cultural and behavioural
factors recognized as the facilitating and barriers to the
use of IFA supplements are important for the develop-
ment of interventions. There is a need to develop and
apply behaviour change communication interventions,
possibly using mobile technologies, to improve the cover-
age of antenatal IFA supplementation.
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